IS5719A - Meðferðar samsetningar sem samanstanda af valvísum estrógen viðtaka beini (modulator) og kalkkirtilshormóni - Google Patents

Meðferðar samsetningar sem samanstanda af valvísum estrógen viðtaka beini (modulator) og kalkkirtilshormóni

Info

Publication number: IS5719A
Authority: IS; Iceland
Prior art keywords: estrogen receptor; parathyroid hormone; receptor modulator; selective estrogen; treatment combinations
Prior art date: 1998-06-16

Application number

IS5719A

Other languages

English (en)

Inventor

Zhu Ke Hua

Duane Thompson David

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-16

Filing date

2000-11-21

Publication date

2000-11-21

2000-11-21 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2000-11-21 Publication of IS5719A publication Critical patent/IS5719A/is

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Physical Education & Sports Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)

IS5719A 1998-06-16 2000-11-21 Meðferðar samsetningar sem samanstanda af valvísum estrógen viðtaka beini (modulator) og kalkkirtilshormóni IS5719A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8947998P	1998-06-16	1998-06-16
PCT/IB1999/000949 WO1999065482A1 (en)	1998-06-16	1999-05-26	Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone

Publications (1)

Publication Number	Publication Date
IS5719A true IS5719A (is)	2000-11-21

Family

ID=22217879

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5719A IS5719A (is)	1998-06-16	2000-11-21	Meðferðar samsetningar sem samanstanda af valvísum estrógen viðtaka beini (modulator) og kalkkirtilshormóni

Country Status (34)

Country	Link
US (1)	US6132774A (is)
EP (1)	EP1094808A1 (is)
JP (1)	JP2002518323A (is)
KR (1)	KR20010052818A (is)
CN (1)	CN1305373A (is)
AP (1)	AP9901580A0 (is)
AR (1)	AR018867A1 (is)
AU (1)	AU3725999A (is)
BG (1)	BG105125A (is)
BR (1)	BR9911228A (is)
CA (1)	CA2335078A1 (is)
CO (1)	CO5070584A1 (is)
EA (1)	EA200001199A1 (is)
GT (1)	GT199900066A (is)
HN (1)	HN1999000063A (is)
HR (1)	HRP20000858A2 (is)
HU (1)	HUP0102759A3 (is)
ID (1)	ID26873A (is)
IL (1)	IL139588A0 (is)
IS (1)	IS5719A (is)
MA (1)	MA26649A1 (is)
NO (1)	NO20006313L (is)
NZ (1)	NZ508039A (is)
OA (1)	OA11566A (is)
PA (1)	PA8471201A1 (is)
PE (1)	PE20000644A1 (is)
PL (1)	PL344982A1 (is)
SK (1)	SK18922000A3 (is)
TN (1)	TNSN99119A1 (is)
TR (1)	TR200003567T2 (is)
UA (1)	UA60367C2 (is)
WO (1)	WO1999065482A1 (is)
YU (1)	YU75800A (is)
ZA (1)	ZA993972B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HN1996000101A (es) *	1996-02-28	1997-06-26	Inc Pfizer	Terapia combinada para la osteoporosis
US20020107230A1 (en) *	2000-12-22	2002-08-08	Waldon R. Forrest	Methods and formulations for the treatment of female sexual dysfunction
US20030191096A1 (en) *	2002-04-03	2003-10-09	Leonard Thomas W.	Method of hormonal therapy
JP2007512359A (ja)	2003-11-19	2007-05-17	メタバシス・セラピューティクス・インコーポレイテッド	新規なリン含有甲状腺ホルモン様物質
MX2007005137A (es) *	2004-11-23	2007-06-22	Warner Lambert Co	Derivados del acido 7-(2h-pyrazol-3-il)-3, 5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de lipidemia.
US7790745B2 (en)	2005-10-21	2010-09-07	Bristol-Myers Squibb Company	Tetrahydroisoquinoline LXR Modulators
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
US7919506B2 (en)	2006-03-10	2011-04-05	Pfizer Inc.	Dibenzyl amine compounds and derivatives
WO2008070496A2 (en)	2006-12-01	2008-06-12	Bristol-Myers Squibb Company	N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US20120046364A1 (en)	2009-02-10	2012-02-23	Metabasis Therapeutics, Inc.	Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
TW201043595A (en) *	2009-03-13	2010-12-16	Organon Nv	Tetrahydronaphthalen-2-ol derivatives
DE102010027016A1 (de)	2010-07-09	2012-01-12	Universitätsklinikum Jena	Steroid-Styrylfarbstoff-Konjugate zur Simulation und direkten lichtoptischen Detektion des Verhaltens von Steroiden im lebenden biologischen Gewebe und in Gegenwart von steroidbindenden Proteinen
CN111067907A (zh) *	2018-10-18	2020-04-28	常州大学	孕激素在抑制血管内皮生长因子表达中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5254595A (en) *	1988-12-23	1993-10-19	Elf Sanofi	Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them
US5552412A (en) *	1995-01-09	1996-09-03	Pfizer Inc	5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
TW432073B (en) *	1995-12-28	2001-05-01	Pfizer	Pyrazolopyridine compounds
HN1996000101A (es) *	1996-02-28	1997-06-26	Inc Pfizer	Terapia combinada para la osteoporosis

1999
- 1999-04-29 PA PA19998471201A patent/PA8471201A1/es unknown
- 1999-05-03 HN HN1999000063A patent/HN1999000063A/es unknown
- 1999-05-10 GT GT199900066A patent/GT199900066A/es unknown
- 1999-05-26 WO PCT/IB1999/000949 patent/WO1999065482A1/en not_active Ceased
- 1999-05-26 JP JP2000554362A patent/JP2002518323A/ja active Pending
- 1999-05-26 NZ NZ508039A patent/NZ508039A/xx unknown
- 1999-05-26 OA OA1200000340A patent/OA11566A/en unknown
- 1999-05-26 CA CA002335078A patent/CA2335078A1/en not_active Abandoned
- 1999-05-26 UA UA2000127244A patent/UA60367C2/uk unknown
- 1999-05-26 IL IL13958899A patent/IL139588A0/xx unknown
- 1999-05-26 BR BR9911228-0A patent/BR9911228A/pt not_active IP Right Cessation
- 1999-05-26 PL PL99344982A patent/PL344982A1/xx unknown
- 1999-05-26 AU AU37259/99A patent/AU3725999A/en not_active Abandoned
- 1999-05-26 HR HR20000858A patent/HRP20000858A2/hr not_active Application Discontinuation
- 1999-05-26 KR KR1020007014141A patent/KR20010052818A/ko not_active Ceased
- 1999-05-26 CN CN99807345A patent/CN1305373A/zh active Pending
- 1999-05-26 TR TR2000/03567T patent/TR200003567T2/xx unknown
- 1999-05-26 YU YU75800A patent/YU75800A/sh unknown
- 1999-05-26 SK SK1892-2000A patent/SK18922000A3/sk unknown
- 1999-05-26 ID IDW20002626A patent/ID26873A/id unknown
- 1999-05-26 EA EA200001199A patent/EA200001199A1/ru unknown
- 1999-05-26 HU HU0102759A patent/HUP0102759A3/hu unknown
- 1999-05-26 US US09/424,010 patent/US6132774A/en not_active Expired - Fee Related
- 1999-05-26 EP EP99919491A patent/EP1094808A1/en not_active Withdrawn
- 1999-06-10 AP APAP/P/1999/001580A patent/AP9901580A0/en unknown
- 1999-06-14 PE PE1999000526A patent/PE20000644A1/es not_active Application Discontinuation
- 1999-06-15 ZA ZA9903972A patent/ZA993972B/xx unknown
- 1999-06-15 AR ARP990102846A patent/AR018867A1/es not_active Application Discontinuation
- 1999-06-15 MA MA25623A patent/MA26649A1/fr unknown
- 1999-06-15 TN TNTNSN99119A patent/TNSN99119A1/fr unknown
- 1999-06-16 CO CO99037623A patent/CO5070584A1/es unknown
2000
- 2000-11-21 IS IS5719A patent/IS5719A/is unknown
- 2000-12-12 NO NO20006313A patent/NO20006313L/no not_active Application Discontinuation
2001
- 2001-01-08 BG BG105125A patent/BG105125A/xx unknown

Also Published As

Publication number	Publication date
PE20000644A1 (es)	2000-08-02
NZ508039A (en)	2003-03-28
HRP20000858A2 (en)	2001-10-31
KR20010052818A (ko)	2001-06-25
PA8471201A1 (es)	2000-09-29
AR018867A1 (es)	2001-12-12
WO1999065482A1 (en)	1999-12-23
PL344982A1 (en)	2001-11-19
YU75800A (sh)	2003-12-31
AU3725999A (en)	2000-01-05
OA11566A (en)	2004-05-26
GT199900066A (es)	2000-10-31
ID26873A (id)	2001-02-15
BG105125A (en)	2001-11-30
CO5070584A1 (es)	2001-08-28
SK18922000A3 (sk)	2001-09-11
US6132774A (en)	2000-10-17
CN1305373A (zh)	2001-07-25
JP2002518323A (ja)	2002-06-25
NO20006313D0 (no)	2000-12-12
TR200003567T2 (tr)	2001-06-21
HUP0102759A2 (hu)	2002-03-28
TNSN99119A1 (fr)	2005-11-10
IL139588A0 (en)	2002-02-10
BR9911228A (pt)	2001-02-13
HUP0102759A3 (en)	2002-12-28
HN1999000063A (es)	2000-01-12
AP9901580A0 (en)	1999-06-30
ZA993972B (en)	2000-12-15
EP1094808A1 (en)	2001-05-02
MA26649A1 (fr)	2004-12-20
CA2335078A1 (en)	1999-12-23
UA60367C2 (uk)	2003-10-15
EA200001199A1 (ru)	2001-04-23
NO20006313L (no)	2000-12-12

Publication	Publication Date	Title
IS5719A (is)	2000-11-21	Meðferðar samsetningar sem samanstanda af valvísum estrógen viðtaka beini (modulator) og kalkkirtilshormóni
NO995845L (no)	2000-01-27	Ikke-steroide, (hetero) syklisk-substituerte acylanilider med blandet gestagen- og androgen virkning
FI982002L (fi)	2000-03-17	Menetelmä ja laite radioresurssin dynaamiseksi ohjaamiseksi
GB0116451D0 (en)	2001-08-29	Bone cement mixer and method
IL204486A0 (en)	2011-08-01	Selective androgen receptor modulators and methods of uses thereof
IL155068A0 (en)	2003-10-31	Flow scheduling and architecture for network application apparatus
AU1179200A (en)	2000-06-05	Exposure method and device
DK1082155T3 (da)	2007-01-29	Dispersions-apparater til törpulver og fremgangsmåder til anvendelse af sådanne
GB0118794D0 (en)	2001-09-26	Wafer edge engineering method and device
IL138828A0 (en)	2002-11-10	A method and system for assigning human resources to provide services
AU2002235130A8 (en)	2009-07-30	Method and system for providing communications services
SG113388A1 (en)	2005-08-29	Exposure method and exposure apparatus
AU2076099A (en)	1999-08-16	Exposure method and device
NO993680L (no)	2000-01-31	Forankringsanordning og fremgangsmåte
DE69820278D1 (de)	2004-01-15	Mischverfahren und mischvorrichtung
DE59813626D1 (de)	2006-08-10	Kommunikationssystem, kommunikationsverfahren und dafür geeignete vorrichtungen
DE60030644D1 (de)	2006-10-26	Maskendruckverfahren und Maskendruckvorrichtung
DK1140824T3 (da)	2004-09-13	Fremgangsmåde til fremstilling af 3-alkanoyl- og 3-alkylindoler
ATE215819T1 (de)	2002-04-15	Transdermales therapeutisches system, enthaltend hormone und kristallisationsinhibitoren
AU1365102A (en)	2002-05-15	Pour-on application method and devices
DK0956022T3 (da)	2003-08-04	Hormonpræparat indeholdende en østrogenforbindelse og en progestativ forbindelse
NO20015795L (no)	2002-05-29	Digitalt satellitt-kommunikasjonssystem og -fremgangsmåte
EP1049107A4 (en)	2002-10-16	METHOD AND DEVICE FOR ACTIVATING A SUBSTANCE
NO20006381D0 (no)	2000-12-14	Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler
IS5691A (is)	2000-10-27	Meðferðarsamsetningar af (valvísum) estrógen viðtaka beinum (SERM) og vaxtarhormóns seytum (GHS) til meðhöndlunar á veikleika í beinagrindarvöðva